Oyster Point Pharma

Pharmaceuticals

United States, New Jersey

$100M to $250M

201-500

Smith Drug Company

Pharmaceuticals

United States, South Carolina

$100M to $250M

201-500

PerformRx

Pharmaceuticals

United States, Pennsylvania

$100M to $250M

201-500

Radius Health

Pharmaceuticals

United States, Massachusetts

$100M to $250M

201-500

NorthStar Medical Radioisotopes

Pharmaceuticals

United States, Wisconsin

$100M to $250M

201-500

Catalyst Clinical Research

Pharmaceuticals

United States, North Carolina

$100M to $250M

201-500

Topix Pharmaceuticals

Pharmaceuticals

United States, New York

$100M to $250M

201-500

Elligo Health Research

Pharmaceuticals

United States, Texas

$100M to $250M

201-500

Norwich Pharma Services

Pharmaceuticals

United States, New York

$100M to $250M

201-500

Karyopharm Therapeutics

Pharmaceuticals

United States, Massachusetts

$100M to $250M

201-500

Recordati Rare Diseases North America

Pharmaceuticals

United States, New Jersey

$100M to $250M

201-500

Noven Pharmaceuticals

Pharmaceuticals

United States, Florida

$100M to $250M

201-500

Kowa Pharmaceuticals America

Pharmaceuticals

United States, Alabama

$100M to $250M

201-500

Clinical ink

Pharmaceuticals

United States, North Carolina

$100M to $250M

201-500

Zogenix

Pharmaceuticals

United States, California

$100M to $250M

201-500

Athenex

Pharmaceuticals

United States, New York

$100M to $250M

201-500

Technical Resources International

Pharmaceuticals

United States, Maryland

$100M to $250M

201-500

Acreage Holdings

Pharmaceuticals

United States, New York

$100M to $250M

201-500

Portola Pharmaceuticals

Pharmaceuticals

United States, California

$100M to $250M

201-500

Sebela Pharmaceuticals

Pharmaceuticals

United States, Georgia

$100M to $250M

201-500